EXPERT ANALYSIS AT THE NPA PSYCHOPHARMACOLOGY UPDATE
Dr. Doghramji disclosed that he is a consultant for UCB, Teva Pharmaceuticals, Vanda Pharmaceuticals, and Jazz Pharmaceuticals, and that he holds stock in Merck.
dbrunk@frontlinemedcom.com
